News Image

Exploring growth characteristics of ALKERMES PLC (NASDAQ:ALKS).

By Mill Chart

Last update: May 2, 2024

Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if ALKERMES PLC (NASDAQ:ALKS) is suited for growth investing. Investors should of course do their own research, but we spotted ALKERMES PLC showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.

Exploring Why NASDAQ:ALKS Holds Promise for Growth Investors.

  • ALKERMES PLC has a healthy Return on Equity(ROE) of 29.59%. This demonstrates the company's efficient utilization of capital and indicates its commitment to driving profitability.
  • ALKERMES PLC has surpassed EPS estimates 3 times in the last 4 quarters, reflecting its strong financial performance and effective management. This trend suggests the company's ability to generate positive earnings surprises and drive shareholder value.
  • With notable 1-year revenue growth of 49.61%, ALKERMES PLC exemplifies its ability to generate increased sales and revenue streams. This growth signifies the company's strong business performance and its potential for future growth.
  • The quarter-to-quarter (Q2Q) revenue growth of 23.88% of ALKERMES PLC has been strong, reflecting the company's ability to generate consistent sales growth. This growth suggests the company's ability to meet customer needs and drive revenue growth.
  • ALKERMES PLC has experienced notable growth in its operating margin over the past year, reflecting improved operational performance. This growth suggests the company's ability to generate higher profits from its core business activities.
  • The free cash flow (FCF) of ALKERMES PLC has seen steady growth over the past year, indicating enhanced cash flow generation and financial health. This trend underscores the company's effective capital management and its ability to generate sustainable cash flows.
  • In the most recent financial report, ALKERMES PLC reported a 57.14% increase in quarterly earnings compared to the previous quarter. This notable growth indicates positive momentum in the company's financials, suggesting an upward trend
  • The average next Quarter EPS Estimate by analysts was adjusted by 24.19%, reflecting the evolving market expectations for the company's EPS growth.
  • The recent financial report of ALKERMES PLC demonstrates a 57.14% increase in quarterly earnings compared to the previous quarter. This growth indicates positive momentum in the company's financials and suggests a promising upward trend
  • accelerating EPS growth for ALKERMES PLC: the current Q2Q growth of 57.14% exceeds the previous year Q2Q growth of -39.13%.

Fundamental analysis of NASDAQ:ALKS

Every day, ChartMill assigns a Fundamental Rating to each stock, providing a score ranging from 0 to 10. This rating is determined by evaluating various fundamental indicators and properties.

Taking everything into account, ALKS scores 6 out of 10 in our fundamental rating. ALKS was compared to 588 industry peers in the Biotechnology industry. ALKS has an excellent financial health rating, but there are some minor concerns on its profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on ALKS. These ratings could make ALKS a good candidate for value investing.

Our latest full fundamental report of ALKS contains the most current fundamental analsysis.

More ideas for growth investing can be found on ChartMill in our Lois Navellier screen.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

ALKERMES PLC

NASDAQ:ALKS (5/9/2024, 8:33:05 AM)

24.27

+0.17 (+0.71%)

ALKS News

News Imagea day ago - ChartmillInvestors should take notice of NASDAQ:ALKS—it offers a great deal for the fundamentals it presents.

ALKERMES PLC (NASDAQ:ALKS) is probably undervalued for the fundamentals it is displaying.

News Image7 days ago - Alkermes plcAlkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility in Athlone, Ireland to...

News Image7 days ago - ChartmillExploring growth characteristics of ALKERMES PLC (NASDAQ:ALKS).

Should you consider ALKERMES PLC (NASDAQ:ALKS) for growth investing?

News Image8 days ago - InvestorPlaceALKS Stock Earnings: Alkermes Misses EPS, Misses Revenue for Q1 2024

ALKS stock results show that Alkermes missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

News Image15 days ago - Alkermes plcAlkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced initiation of the Vibrance-1 study, a phase 2 clinical trial evaluating the safety and efficacy of...

News Image20 days ago - Market News VideoFirst Week of June 21st Options Trading For Alkermes (ALKS)
News Image22 days ago - Alkermes plcAlkermes to Report First Quarter Financial Results on May 1, 2024

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, May 1, 2024 to...

News Imagea month ago - Market News VideoOversold Conditions For Alkermes (ALKS)
News Imagea month ago - Alkermes plcAlkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the oral presentation of clinical data at the 2024 Congress of the Schizophrenia International...

News Imagea month ago - Market News VideoNoteworthy Tuesday Option Activity: ALKS, DKNG, VRT
News Image2 months ago - Market News VideoFirst Week of ALKS November 15th Options Trading
ALKS Links
Follow us for more